Literature DB >> 26879989

Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time.

Nicolas Aznar1, Nicholas Kalogriopoulos1, Krishna K Midde1, Pradipta Ghosh1,2.   

Abstract

Canonical signal transduction via heterotrimeric G proteins is spatially and temporally restricted, that is, triggered exclusively at the plasma membrane (PM), only by agonist activation of G protein-coupled receptors (GPCRs) via a process that completes within a few hundred milliseconds. Recently, a rapidly emerging paradigm has revealed a non-canonical pathway for activation of heterotrimeric G proteins by the non-receptor guanidine-nucleotide exchange factor (GEF), GIV/Girdin. This pathway has distinctive temporal and spatial features and an unusual profile of receptor engagement: diverse classes of receptors, not just GPCRs can engage with GIV to trigger such activation. Such activation is spatially and temporally unrestricted, that is, can occur both at the PM and on internal membranes discontinuous with the PM, and can continue for prolonged periods of time. Here, we provide the most complete up-to-date review of the molecular mechanisms that govern the unique spatiotemporal aspects of non-canonical G protein activation by GIV and the relevance of this new paradigm in health and disease.
© 2016 WILEY Periodicals, Inc.

Entities:  

Keywords:  Golgi; autophagy; cdk5: Girdin; growth factor receptor tyrosine kinases; heterotrimeric G proteins

Mesh:

Substances:

Year:  2016        PMID: 26879989      PMCID: PMC5123561          DOI: 10.1002/bies.201500133

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  109 in total

1.  The Akt substrate Girdin is a regulator of insulin signaling in myoblast cells.

Authors:  Angelika Hartung; Anna-Maria Ordelheide; Harald Staiger; Martina Melzer; Hans-Ulrich Häring; Reiner Lammers
Journal:  Biochim Biophys Acta       Date:  2013-07-23

2.  A novel Drosophila Girdin-like protein is involved in Akt pathway control of cell size.

Authors:  Aekkachai Puseenam; Yasuhide Yoshioka; Rika Nagai; Reina Hashimoto; Osamu Suyari; Masanobu Itoh; Atsushi Enomoto; Masahide Takahashi; Masamitsu Yamaguchi
Journal:  Exp Cell Res       Date:  2009-06-26       Impact factor: 3.905

Review 3.  New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades.

Authors:  K L Pierce; L M Luttrell; R J Lefkowitz
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

4.  Activation of Gαi at the Golgi by GIV/Girdin imposes finiteness in Arf1 signaling.

Authors:  I-Chung Lo; Vijay Gupta; Krishna K Midde; Vanessa Taupin; Inmaculada Lopez-Sanchez; Irina Kufareva; Ruben Abagyan; Paul A Randazzo; Marilyn G Farquhar; Pradipta Ghosh
Journal:  Dev Cell       Date:  2015-04-09       Impact factor: 12.270

5.  Src homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway.

Authors:  Yash Mittal; Yelena Pavlova; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

6.  Girdin phosphorylation is crucial for synaptic plasticity and memory: a potential role in the interaction of BDNF/TrkB/Akt signaling with NMDA receptor.

Authors:  Tsuyoshi Nakai; Taku Nagai; Motoki Tanaka; Norimichi Itoh; Naoya Asai; Atsushi Enomoto; Masato Asai; Shinnosuke Yamada; Ali Bin Saifullah; Masahiro Sokabe; Masahide Takahashi; Kiyofumi Yamada
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

7.  The Ras-related protein AGS1/RASD1 suppresses cell growth.

Authors:  Govindan Vaidyanathan; Mary J Cismowski; Guoshun Wang; Timothy S Vincent; Kevin D Brown; Stephen M Lanier
Journal:  Oncogene       Date:  2004-07-29       Impact factor: 9.867

8.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.

Authors:  H Daub; F U Weiss; C Wallasch; A Ullrich
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

9.  Coactivation of G protein signaling by cell-surface receptors and an intracellular exchange factor.

Authors:  Michael J Lee; Henrik G Dohlman
Journal:  Curr Biol       Date:  2008-02-12       Impact factor: 10.834

10.  Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.

Authors:  Hiroki Miyachi; Shinji Mii; Atsushi Enomoto; Yoshiki Murakumo; Takuya Kato; Naoya Asai; Kimihiro Komori; Masahide Takahashi
Journal:  J Vasc Surg       Date:  2013-08-12       Impact factor: 4.268

View more
  25 in total

Review 1.  Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".

Authors:  Michael Getz; Padmini Rangamani; Pradipta Ghosh
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-04-23

2.  Structural basis for GPCR-independent activation of heterotrimeric Gi proteins.

Authors:  Nicholas A Kalogriopoulos; Steven D Rees; Tony Ngo; Noah J Kopcho; Andrey V Ilatovskiy; Nina Sun; Elizabeth A Komives; Geoffrey Chang; Pradipta Ghosh; Irina Kufareva
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-30       Impact factor: 11.205

3.  Biochemical, Biophysical and Cellular Techniques to Study the Guanine Nucleotide Exchange Factor, GIV/Girdin.

Authors:  Pradipta Ghosh; Nicolas Aznar; Lee Swanson; I-Chung Lo; Inmaculada Lopez-Sanchez; Jason Ear; Cristina Rohena; Nicholas Kalogriopoulos; Linda Joosen; Ying Dunkel; Nina Sun; Peter Nguyen; Deepali Bhandari
Journal:  Curr Protoc Chem Biol       Date:  2016-12-07

Review 4.  The GAPs, GEFs, GDIs and…now, GEMs: New kids on the heterotrimeric G protein signaling block.

Authors:  Pradipta Ghosh; Padmini Rangamani; Irina Kufareva
Journal:  Cell Cycle       Date:  2017-03-13       Impact factor: 4.534

5.  Receptor tyrosine kinases activate heterotrimeric G proteins via phosphorylation within the interdomain cleft of Gαi.

Authors:  Nicholas A Kalogriopoulos; Inmaculada Lopez-Sanchez; Changsheng Lin; Tony Ngo; Krishna K Midde; Suchismita Roy; Nicolas Aznar; Fiona Murray; Mikel Garcia-Marcos; Irina Kufareva; Majid Ghassemian; Pradipta Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

6.  GIV/Girdin activates Gαi and inhibits Gαs via the same motif.

Authors:  Vijay Gupta; Deepali Bhandari; Anthony Leyme; Nicolas Aznar; Krishna K Midde; I-Chung Lo; Jason Ear; Ingrid Niesman; Inmaculada López-Sánchez; Juan Bautista Blanco-Canosa; Mark von Zastrow; Mikel Garcia-Marcos; Marilyn G Farquhar; Pradipta Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

7.  Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers.

Authors:  Ying Dunkel; Kexin Diao; Nicolas Aznar; Lee Swanson; Lawrence Liu; Wenhong Zhu; Xiao-Yi Mi; Pradipta Ghosh
Journal:  FASEB J       Date:  2016-07-20       Impact factor: 5.191

8.  Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.

Authors:  Pradipta Ghosh; Jeanne Tie; Andrea Muranyi; Shalini Singh; Patrick Brunhoeber; Katherine Leith; Rebecca Bowermaster; Zhiming Liao; Yifei Zhu; Bonnie LaFleur; Ben Tran; Jayesh Desai; Ian Jones; Matthew Croxford; Rodrigo Jover; Ajay Goel; Paul Waring; Song Hu; Volker Teichgraber; Ulrich-Peter Rohr; Ruediger Ridder; Kandavel Shanmugam; Peter Gibbs
Journal:  Clin Cancer Res       Date:  2016-03-30       Impact factor: 12.531

Review 9.  The untapped potential of tyrosine-based G protein signaling.

Authors:  Pradipta Ghosh
Journal:  Pharmacol Res       Date:  2016-01-22       Impact factor: 7.658

10.  TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin.

Authors:  Lee Swanson; Gajanan D Katkar; Julian Tam; Rama F Pranadinata; Yogitha Chareddy; Jane Coates; Mahitha Shree Anandachar; Vanessa Castillo; Joshua Olson; Victor Nizet; Irina Kufareva; Soumita Das; Pradipta Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.